MCP
Mirador Capital Partners’s 10x Genomics TXG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $920K | Sell |
79,443
-814
| -1% | -$9.43K | 0.15% | 98 |
|
|
2025
Q1 | $701K | Sell |
80,257
-726
| -0.9% | -$6.34K | 0.12% | 112 |
|
|
2024
Q4 | $1.16M | Buy |
80,983
+22,792
| +39% | +$327K | 0.21% | 79 |
|
|
2024
Q3 | $1.31M | Sell |
58,191
-3,776
| -6% | -$85.3K | 0.24% | 67 |
|
|
2024
Q2 | $1.21M | Buy |
61,967
+33,142
| +115% | +$645K | 0.23% | 68 |
|
|
2024
Q1 | $1.08M | Buy |
28,825
+940
| +3% | +$35.3K | 0.21% | 80 |
|
|
2023
Q4 | $1.56M | Buy |
27,885
+521
| +2% | +$29.2K | 0.33% | 59 |
|
|
2023
Q3 | $1.13M | Sell |
27,364
-4,480
| -14% | -$185K | 0.26% | 72 |
|
|
2023
Q2 | $1.78M | Sell |
31,844
-1,205
| -4% | -$67.3K | 0.42% | 59 |
|
|
2023
Q1 | $1.84M | Buy |
33,049
+6,478
| +24% | +$361K | 0.44% | 54 |
|
|
2022
Q4 | $968K | Sell |
26,571
-1,710
| -6% | -$62.3K | 0.23% | 73 |
|
|
2022
Q3 | $805K | Buy |
28,281
+12,587
| +80% | +$358K | 0.19% | 79 |
|
|
2022
Q2 | $710K | Sell |
15,694
-6,253
| -28% | -$283K | 0.17% | 94 |
|
|
2022
Q1 | $1.67M | Buy |
21,947
+464
| +2% | +$35.3K | 0.34% | 64 |
|
|
2021
Q4 | $3.2M | Buy |
21,483
+1,353
| +7% | +$202K | 0.67% | 46 |
|
|
2021
Q3 | $2.93M | Buy |
20,130
+4,519
| +29% | +$658K | 0.67% | 45 |
|
|
2021
Q2 | $3.06M | Buy |
15,611
+1,425
| +10% | +$279K | 0.69% | 49 |
|
|
2021
Q1 | $2.57M | Sell |
14,186
-191
| -1% | -$34.6K | 0.66% | 48 |
|
|
2020
Q4 | $2.04M | Buy |
14,377
+938
| +7% | +$133K | 0.56% | 59 |
|
|
2020
Q3 | $1.68M | Buy |
13,439
+588
| +5% | +$73.3K | 0.52% | 56 |
|
|
2020
Q2 | $1.15M | Buy |
12,851
+557
| +5% | +$49.8K | 0.43% | 58 |
|
|
2020
Q1 | $968K | Buy |
12,294
+7,994
| +186% | +$629K | 0.4% | 60 |
|
|
2019
Q4 | $328K | Buy |
+4,300
| New | +$328K | 0.13% | 133 |
|